Patent protection for new uses of known drugs

This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight

“The most effective way to move from target identification to the clinic is to identify already approved drugs with the potential for activating or inhibiting unintended targets.” (S Dakshanamurthy et al, J Med Chem, 2012, 55(15), pp6832–6848.)


Unlock unlimited access to all IAM content